Premium
P4‐101: REGIONAL VARIATION IN ALZHEIMER'S DISEASE PROGRESSION IN A CLINICAL TRIAL SETTING
Author(s) -
Henley David B.,
Dowsett Sherie A.,
Chen YunFei,
LiuSeifert Hong,
Grill Joshua D.,
Doody Rachelle,
Aisen Paul,
Raman Rema,
Miller David S.,
Hake Ann Marie,
Cummings Jeffrey
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1617
Subject(s) - medicine , placebo , clinical trial , disease , randomized controlled trial , physical therapy , clinical endpoint , memantine , gerontology , dementia , pathology , alternative medicine
David B. Henley, Sherie A. Dowsett, Yun-Fei Chen, Hong Liu-Seifert, Joshua D. Grill, Rachelle Doody, Paul Aisen, Rema Raman, David S. Miller, Ann Marie Hake, Jeffrey Cummings, Eli Lilly and Company, Indianapolis, Indiana, United States; UCLA, Los Angeles, California, United States; Baylor College of Medicine, Houston, Texas, United States; UCSD, La Jolla, California, United States; UCSD, San Diego, California, United States; Bracket, Wayne, Pennsylvania, United States; Eli Lilly and Company, Indianapolis, Indiana, United States; Cleveland Clinic Lou Ruvo Center, Las Vegas, Nevada, United States. Contact e-mail: henley_david_benjamin@lilly.com